Last reviewed: June 9, 2026
Last updated: June 9, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
GLP-1 receptor agonists activate hormonal signals in your brain and pancreas that control hunger and blood glucose levels. Clinical trials show these medications help people lose 15–22% of body weight over 68 weeks. Determining whether GLP-1 therapy is right for you requires understanding your health profile, current medications, and weight loss goals.
What Are GLP-1 Agonists and How Do They Work?
GLP-1 (glucagon-like peptide-1) is a natural hormone your intestines release when you eat. It tells your pancreas to release insulin, slows stomach emptying, and sends fullness signals to your brain. GLP-1 receptor agonists are medications designed to mimic this hormone, making these signals stronger and longer-lasting. Semaglutide and tirzepatide are the two most widely studied compounds in this drug class.
When you take a GLP-1 agonist, your appetite decreases, portion sizes feel more satisfying, and blood sugar spikes after meals become smaller. These effects compound over weeks, leading to consistent weight loss without requiring extreme dietary restriction. The medication works on multiple pathways at once—unlike older weight loss drugs that targeted only one mechanism.
Who Is a Good Candidate for GLP-1 Treatment?
You may be a good candidate for GLP-1 agonists if you have a BMI of 30 or higher, or a BMI of 27+ with weight-related health conditions like high blood pressure or type 2 diabetes. You should also have realistic expectations: GLP-1 therapy works best alongside modest lifestyle changes, not as a substitute for them. A thorough health assessment by a licensed provider identifies whether your current medications, medical history, or existing conditions create any safety concerns.
Certain medical situations require caution or exclusion from GLP-1 use, including a personal or family history of medullary thyroid cancer, severe kidney disease, or active pancreatitis. Pregnancy and breastfeeding are also contraindications. PlexusDx providers review your full medical picture before recommending treatment, ensuring you receive only therapies that are safe and appropriate for your unique circumstances.
Clinical Evidence: Weight Loss, Metabolic Health, and Long-Term Outcomes
The SUSTAIN and STEP trials, which followed thousands of participants over 2–3 years, demonstrated that semaglutide produces sustained weight loss of 15–22% from baseline—far exceeding older weight loss medications. Participants also saw improvements in blood pressure, triglycerides, and insulin resistance. These benefits persisted for the duration of treatment, showing that GLP-1 agonists work consistently when taken as directed.
Tirzepatide, which activates both GLP-1 and GIP receptors, showed even larger weight reductions in the SURPASS trial series—up to 22% body weight loss in some cohorts. Beyond weight metrics, patients reported better energy levels, improved sleep quality, and reduced cravings for high-calorie foods. The cardiovascular benefits observed in these trials suggest GLP-1 agonists may reduce heart attack and stroke risk in people with obesity and diabetes.
Personalized GLP-1 Selection: Injection vs. Oral, and Genetic Insights
PlexusDx offers multiple GLP-1 formats to match your lifestyle and preferences. Compounded semaglutide injection starts at $149/month and delivers consistent absorption through subcutaneous administration once weekly. Oral semaglutide provides a tablet option at $249/month for patients who prefer to avoid needles, though absorption is less predictable with food and other medications. Tirzepatide injection ($249/month) and oral tirzepatide ($279/month) activate additional receptor pathways, often producing greater appetite suppression.
For deeper personalization, PlexusDx offers the Precision Peptide Genetic Test ($99 add-on after your first month). This test analyzes how your DNA influences key weight regulation genes—including GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, and MC4R rs17782313—across 14 metabolic pathways. Understanding your genetic predispositions helps your provider fine-tune which medication and dose strategy will likely give you the best results. Your dose may need to go up. Your price won't.
Common Side Effects and How to Manage Them
Mild gastrointestinal effects—nausea, vomiting, diarrhea, or constipation—occur in 20–40% of users during the first 2–4 weeks as your body adjusts. These symptoms typically fade as your system adapts; starting with a low dose and increasing gradually over 4–16 weeks minimizes discomfort. Eating smaller, lower-fat meals and staying hydrated also reduce nausea severity. Serious side effects are rare in people without contraindications, but persistent vomiting or severe abdominal pain warrant immediate medical attention.
Some patients experience fatigue, headache, or changes in appetite regulation that feel unbalanced at first. These effects usually resolve within weeks and signal that the medication is active in your system. Rarely, pancreatitis (pancreas inflammation) or gallbladder issues occur; these require discontinuation and emergency evaluation. Working with a PlexusDx provider who monitors your progress ensures any emerging concerns are caught early and addressed appropriately.
Cost, Insurance, and Access: Why PlexusDx Makes GLP-1 Affordable
PlexusDx eliminates barriers to GLP-1 access by offering compounded medications from licensed 503A pharmacies at fixed monthly rates—no insurance required, no membership fee, and no hidden charges. Compounded semaglutide injection starts at $149 per month, and your dose may increase over time without raising your price. All PlexusDx medications are HSA/FSA eligible, allowing you to use pre-tax healthcare savings accounts. This pricing model makes precision weight loss therapy accessible to people who face insurance denials, high copays, or lack of coverage altogether.
PlexusDx serves all 50 states with discreet home delivery and secure telemedicine consultations. There are no long-term contracts—you can adjust or pause your plan anytime. Your provider creates a personalized treatment roadmap, starting with the lowest effective dose and escalating based on your response and tolerance. This approach minimizes both side effects and overall cost while maximizing the chance of reaching your weight loss goal.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
I have prediabetes and a BMI of 28. Can I take GLP-1 therapy?
Yes, you may qualify. GLP-1 agonists are approved for people with BMI ≥27 who have weight-related conditions like prediabetes, high blood pressure, or high cholesterol. PlexusDx providers evaluate your full health picture during a telemedicine consultation to confirm eligibility and recommend the best starting dose and medication format for your situation.
What does the clinical evidence say about long-term weight loss with GLP-1?
The SUSTAIN and STEP trials showed sustained weight loss of 15–22% over 2–3 years with semaglutide, while tirzepatide (SURPASS trials) achieved up to 22% loss in some groups. These results persisted for the entire treatment duration, and participants maintained improvements in blood pressure, cholesterol, and blood sugar control. Weight typically returns gradually after stopping the medication.
How much does GLP-1 treatment cost at PlexusDx, and can I use my insurance?
PlexusDx compounded semaglutide injection starts at $149/month with no insurance required and no membership fee. All medications are HSA/FSA eligible. Your dose may increase, but your price stays the same. PlexusDx serves all 50 states with discreet home delivery, making GLP-1 therapy accessible without navigating insurance denials.
What are the most common side effects, and how long do they last?
Mild nausea, constipation, diarrhea, and loss of appetite affect 20–40% of users in the first 2–4 weeks. These effects typically fade as your body adjusts. Serious side effects like pancreatitis are rare in people without contraindications. Starting with a low dose and increasing gradually, plus eating smaller meals, significantly reduces discomfort.
What is the PlexusDx Precision Peptide Genetic Test, and how does it help?
The Precision Peptide Genetic Test ($99 add-on after month one) analyzes your DNA across 14 metabolic pathways and 49 peptides, including key weight regulation genes like GLP1R and FTO variants. Understanding your genetic predispositions helps your PlexusDx provider select the medication and dose strategy most likely to succeed for your body, enabling truly personalized therapy.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Can You Take Creatine on GLP-1 Medications?
How Much Weight Do You Lose on Semaglutide in the First Month?